The Union Budget 2026-27 coming on 1 February 2026 can be a turning point for the healthcare and pharma sector. The industry is not expecting any big-bang announcement, but this budget will decide whether India will remain only a hub of cheap medicines or will become a global innovation leader. Currently public healthcare spending is only 1.9% of GDP, whereas the target was 2.5%. Pharma sector wants R&D push, return of 200% tax deduction and simple GST structure. Infrastructure, hospital beds and rural workforce gap are also big concerns. In simple words, Budget 2026 will not just calculate the expenditure but will decide the roadmap for India’s healthcare future.
Budget 2026: India’s Healthcare Crossroads, journey from 1.9% GDP to 2.5%. Money Live | Budget 2026: India’s Healthcare Crossroads: Journey from 1.9% GDP to 2.5%
